NASDAQ:MEDP

Medpace Holdings Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy MEDP

*Your capital is at risk

$450.82

+5.23 (+1.17%)

At Close: Jun 03, 2026

Medpace Holdings Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -93.66. In total, the insiders bought 420.62K and sold 441.85K MEDP shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-93.66
● Buy	420.62K shares
● Sell	441.85K shares
72% Buy Activity Strong Negative Correlation
Buy Signal Low Confidence Apr 24, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -93.66. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 28, 2026 Buy	Employee Stock Option (Right to Buy) M-Exempt	Ewald Stephen P General Counsel & Corp. Secy.	Officer	16 349 Value: $2.27M
May 28, 2026 Sell	Common Stock S-Sale	Ewald Stephen P General Counsel & Corp. Secy.	Officer	16 349 Value: $7.36M
May 28, 2026 Buy	Common Stock M-Exempt	Ewald Stephen P General Counsel & Corp. Secy.	Officer	16 349 Value: $2.27M
May 15, 2026 Buy	Stock Option (Right to Buy) A-Award	Davenport Fred B Jr Director	Director	1 110 Value: $460.9K
May 15, 2026 Buy	Stock Option (Right to Buy) A-Award	Kraft Robert O. Director	Director	1 110 Value: $460.9K
May 15, 2026 Buy	Stock Option (Right to Buy) A-Award	Mccarthy Cornelius P. Iii Director	Director	1 110 Value: $460.9K
May 15, 2026 Buy	Stock Option (Right to Buy) A-Award	Zander Dani S. Director	Director	1 110 Value: $460.9K
May 15, 2026 Buy	Stock Option (Right to Buy) A-Award	Gwadry-sridhar Femida H. Director	Director	1 110 Value: $460.9K
May 15, 2026 Buy	Stock Option (Right to Buy) A-Award	Carley Brian T Director	Director	1 110 Value: $460.9K
Apr 24, 2026 Buy	Employee Stock Option (Right to Buy) M-Exempt	Brady Kevin M. CFO & Treasurer	C-Suite Officer	7 000 Value: $972.1K
Apr 24, 2026 Buy	Employee Stock Option (Right to Buy) A-Award	Brady Kevin M. CFO & Treasurer	C-Suite Officer	10 000 Value: $4.11M
Apr 24, 2026 Buy	Common Stock M-Exempt	Brady Kevin M. CFO & Treasurer	C-Suite Officer	7 000 Value: $972.1K
Apr 24, 2026 Buy	Employee Stock Option (Right to Buy) A-Award	Ewald Stephen P General Counsel & Corp. Secy.	Officer	10 000 Value: $4.11M
Apr 24, 2026 Buy	Common Stock M-Exempt	Ewald Stephen P General Counsel & Corp. Secy.	Officer	3 500 Value: $486.0K
Apr 24, 2026 Buy	Restricted Stock Unit A-Award	Troendle August J. CEO	CEO / President	10 000 Value: $4.11M
Apr 24, 2026 Buy	Employee Stock Option (Right to Buy) A-Award	Troendle August J. CEO	CEO / President	20 000 Value: $8.21M
Apr 24, 2026 Buy	Employee Stock Option (Right to Buy) M-Exempt	Ewald Stephen P General Counsel & Corp. Secy.	Officer	3 500 Value: $486.0K
Apr 24, 2026 Buy	Restricted Stock Unit A-Award	Ewald Stephen P General Counsel & Corp. Secy.	Officer	5 000 Value: $2.05M
Apr 24, 2026 Buy	Employee Stock Option (Right to Buy) A-Award	Burwig Susan E Exec. Vp, Operations	Officer	10 000 Value: $4.11M
Apr 24, 2026 Buy	Restricted Stock Unit A-Award	Burwig Susan E Exec. Vp, Operations	Officer	5 000 Value: $2.05M
Apr 24, 2026 Buy	Restricted Stock Unit A-Award	Brady Kevin M. CFO & Treasurer	C-Suite Officer	5 000 Value: $2.05M
Mar 31, 2026 Buy	Common Stock M-Exempt	Kraft Robert O. Director	Director	33 Value: $15.8K
Mar 31, 2026 Buy	Restricted Stock Unit M-Exempt	Mccarthy Cornelius P. Iii Director	Director	29 Value: $13.9K
Mar 31, 2026 Buy	Common Stock M-Exempt	Mccarthy Cornelius P. Iii Director	Director	29 Value: $13.9K
Mar 31, 2026 Buy	Restricted Stock Unit M-Exempt	Kraft Robert O. Director	Director	33 Value: $15.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MEDPACE HOLDINGS INC

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory...

Read Full Profile Here